ArticleCureus2025
Effects of Adipose-Derived Stem Cell Extract on Peripheral Nerve Cells.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Adipose-derived stem cells (ADSCs) can be obtained from adipose tissue, which is considered clinically dispensable. ADSCs have the ability to differentiate not only into adipocytes and osteoblasts but also into various other cell types, such as nerve cells and cardiomyocytes. However, the clinical application of ADSCs in stem cell therapy is hampered by the risk of transplant rejection and the need for facilities for their storage and transportation. In comparison, cell extracts (CEs) obtained from stem cells by freeze-thawing and lysis are less tumorigenic and immunogenic. However, there are currently no studies on the application of ADSC-derived CEs (ADSC-CEs) in peripheral nerve regeneration. Therefore, in this study, we investigated the effects of ADSC-CEs on proliferation and neurite extension in peripheral nerve cells. ADSCs were harvested from the inguinal region of mice, and ADSC-CEs were obtained following repeated freeze-thawing of ADSCs. We examined the effects of the ADSC-CEs, added to the culture medium, on glial fibrillary acidic protein (GFAP) expression and proliferation in Schwann cells. Moreover, we examined the effects of the ADSC-CEs on neurite length in DRG neurons and PC12D cells. ADSC-CEs stimulated the proliferation of Schwann cells, elevated GFAP expression in these cells, and promoted the elongation of DRG neuron and PC12D cell projections. Notably, heat treatment of the ADSC-CEs abolished these effects. Together, these findings suggest that ADSC-CEs may have therapeutic application in peripheral nerve regeneration.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.